Medical Director, Oncology Clinical Development – Hematology (Hybrid)

Regulatory Toolkit; Lower Providence Township (PA); Hybrid; USD 223,000 - 371,000; Full time

Benefits offered by this job

Health care and other insurance

Retirement benefits

Paid holidays and vacation

Job summary

GSK seeks a Medical Director in Oncology Clinical Development to lead medical monitoring, data interpretation, and cross-functional collaboration across pivotal studies. You will contribute to protocol design, safety oversight, and regulatory interactions, shaping scientific communications and program strategy.

This hybrid role requires MD/oncology expertise, strong trial leadership, and experience in regulatory environments.

Qualifications

• MD (or equivalent) with board certification or eligibility in oncology/hematology.
• Clinical trial conduct experience, including medical monitoring and data interpretation.
• Experience leading or supporting clinical development activities per GCP/ICH guidelines.
• Ability to work within cross-functional matrix teams and regulatory environments.

Responsibilities

• Lead medical monitoring activities for assigned studies, ensuring safety and protocol compliance.
• Interpret safety and clinical data from a physician perspective and provide insights.
• Contribute to protocol development and key study documents.
• Engage with investigators and KEEs to support study conduct.
• Support regulatory interactions and scientific communications.

Skills

Clinical trial conduct

Medical monitoring

Data interpretation

Cross-functional collaboration

Regulatory submissions

Communication skills

Education

MD or equivalent medical degree

Board certification in oncology/hematology

Clinical research experience

Job description

GSK seeks a Medical Director in Oncology Clinical Development to lead medical monitoring, data interpretation, and cross-functional collaboration across pivotal studies. You will contribute to protocol design, safety oversight, and regulatory interactions, shaping scientific communications and program strategy.

This hybrid role requires MD/oncology expertise, strong trial leadership, and experience in regulatory environments.